• $47.3M
    Market Cap
  • -17.51%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
24,000
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
-24,000
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-15,267
+16.57%
-13,097
-26.00%
-17,698
-82.68%
-102,180
N/A
Depreciation and Amortization Expense
0
-100.00%
31,289
-0.13%
31,329
-0.30%
31,424
N/A
Total Operating Expenses
1.0M
+6.31%
984,790
+192.33%
336,871
-56.01%
765,844
N/A
Operating Profit
-1.0M
+6.31%
-984,790
+192.33%
-336,871
-56.01%
-765,844
N/A
Interest Income
N/A
N/A
N/A
N/A
100,000
N/A
N/A
N/A
Interest Expense
-5,156
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
-5,156
N/A
0
-100.00%
100,000
N/A
0
N/A
Total Nonoperating Income and Expense
-135,134
N/A
N/A
N/A
100,000
N/A
N/A
N/A
Income before Taxes
-1.2M
+20.04%
-984,790
+315.75%
-236,871
-69.07%
-765,844
N/A
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-1.2M
+20.04%
-984,790
+315.75%
-236,871
-69.07%
-765,844
N/A
Net Income from Continuing Operations Applicable to Common
-1.2M
+19.61%
-988,338
+317.25%
-236,871
-69.07%
-765,844
N/A
Basic EPS and Net Income
-0.03
0.00%
-0.03
+200.00%
-0.01
-90.00%
-0.10
N/A
Diluted EPS and Net Income
-0.03
0.00%
-0.03
+200.00%
-0.01
-90.00%
-0.10
N/A
Basic Weighted Average Shares
34.5M
+12.99%
30.6M
+73.18%
17.7M
+0.99%
17.5M
N/A
Diluted Weighted Average Shares
34.5M
+12.99%
30.6M
+73.18%
17.7M
+0.99%
17.5M
N/A
Balance Sheet
Cash and Cash Equivalents
9,422
-33.16%
14,097
-93.51%
217,295
+17,023.33%
1,269
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
9,422
-33.16%
14,097
-93.51%
217,295
+17,023.33%
1,269
N/A
Total Current Assets
39,656
-44.94%
72,021
-67.67%
222,793
+17,456.58%
1,269
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
50,441
N/A
N/A
N/A
N/A
N/A
Total Assets
39,656
-44.94%
72,021
-87.88%
594,313
+47.06%
404,118
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
353,868
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
2.0M
+92.44%
1.0M
+42.86%
715,964
-16.09%
853,224
N/A
Total Long-Term Debt
399,300
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
2.0M
+92.44%
1.0M
+42.86%
715,964
-16.09%
853,224
N/A
Retained Earnings
-16.3M
+7.82%
-15.1M
+6.99%
-14.1M
+1.70%
-13.9M
N/A
Total Stockholders Equity
-1.9M
+102.85%
-950,791
+681.57%
-121,651
-72.91%
-449,106
N/A
Total Shares Outstanding
32.1M
+2.83%
31.2M
+57.94%
19.7M
+12.95%
17.5M
N/A
Cash Flow
Cash from Operating Activities
-417,524
+75.29%
-238,197
-46.35%
-443,974
+68.88%
-262,897
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
100,000
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
412,849
+1,079.60%
34,999
-93.75%
560,000
N/A
N/A
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-2,117.02%
+616.21%
-295.58%
+522.96%
-47.45%
N/A
N/A
N/A
Return on Equity
82.11%
-55.29%
183.65%
+121.26%
83.00%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.02
-71.45%
0.07
-77.38%
0.31
N/A
N/A
N/A
Cash Ratio
0.005
-65.22%
0.01
-95.45%
0.30
N/A
N/A
N/A
Debt-to-Equity Ratio
-0.39
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
18.99
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow